2018 - Quang Trung Ha

Born 1982, M.D. from Vietnam, holds a M.S. in Medical Biology from UiB and was until 2018 a PhD candidate in the Gjertsen group. His research focus was on developing p53-independent and p53-dependent novel therapies for the treatment of acute myeloid leukemia.